The Global Fibromyalgia Treatment Market Growth Accelerated By Rising Adoption Of Non-Pharmacological Therapies
Fibromyalgia Treatment Market |
Fibromyalgia is a musculoskeletal disorder characterized by
widespread pain, fatigue, sleep, memory and mood issues. Non-pharmacological
fibromyalgia treatment includes therapies like physical therapy, meditation,
acupuncture and yoga. These therapies help enhance physical functioning, reduce
depression and anxiety and improve sleep quality. With growing awareness about
the benefits of non-drug therapies for pain management, their adoption has been
increasing significantly.
The global Fibromyalgia Treatment Market is estimated to be valued at US$
1546.59 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The rising adoption of non-pharmacological therapies is one of the major
trends being witnessed in the global fibromyalgia treatment market. According
to recent studies, meditation, physical exercise and mindfulness-based cognitive
behavior therapy have shown effectiveness equivalent to commonly prescribed
medications for fibromyalgia symptoms relief. They offer sustainable pain
management with negligible side-effects. As a result, there is growing
inclination among healthcare practitioners and patients towards non-drug
alternatives. This growing preference for integrated therapeutic approaches
using non-pharmacological techniques in fibromyalgia care is expected to drive
significant growth of the overall market during the forecast period.
Segment
Analysis
The global
fibromyalgia treatment market is segmented on the basis of treatment, route of
administration, and distribution channel. The treatment segment is further
divided into medications and therapies. Medications are the dominating
sub-segment owing to the high adoption of prescription drugs for fibromyalgia
treatment. Key prescription drugs used in fibromyalgia treatment include
duloxetine, pregabalin, milnacipran, and savella.
Key Takeaways
The global fibromyalgia
treatment market analysis is expected to witness high growth over the
forecast period of 2023 to 2030. The global Fibromyalgia Treatment Market is
estimated to be valued at US$ 1546.59 Mn in 2023 and is expected to exhibit a
CAGR of 11% over the forecast period 2023 to 2030.
Regional analysis: North America is
currently the dominant region in the global fibromyalgia treatment market and
is expected to continue its dominance over the forecast period. This is
attributed to the increasing prevalence of fibromyalgia and higher adoption of
advanced treatment options in the region. Europe is also expected to witness
above-average growth owing to growing awareness regarding available
fibromyalgia treatment options. Asia Pacific is estimated to be the
fastest-growing region due to rising healthcare expenditure and increasing
patient pool.
Key players: Key players operating in the fibromyalgia treatment market include
Autodesk Inc., IES (Integrated Environmental Solutions), Bentley Systems,
EnergyPlus, CY
PE Software, DesignBuilder Software, IESVE (IES Virtual
Environment), Carrier, eQUEST, Trane Technologies, IES TaP, IES SCAN, Trimble,
and EnergySoft. Autodesk Inc., Bentley Systems, and Trimble collectively
account for the dominant market share currently due to their extensive product
portfolios for structural design and construction management.
Get more
insights on this topic https://www.newswirestats.com/fibromyalgia-treatment-market-industry-insights-trendsfibromyalgia-treatment-market-2023-2030/
Comments
Post a Comment